The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study

The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study

Abstract Background Substance use disorders (SUD) often co-occur with attention deficit hyperactivity disorder (ADHD). Although the short-term effects of some specific interventions have been investigated in randomized clinical trials, little is known about the long-term clinical course of treatment...

Full description

Bibliographic Details
Main Authors: Christoffer Brynte, Myriam Aeschlimann, Csaba Barta, Alex Hendikus Abraham Begeman, Amanda Bäcker, Cleo Lina Crunelle, Constanza Daigre, Laura De Fuentes-Merillas, Zsolt Demetrovics, Geert Dom, Lara Grau López, Romain Icick, Brian Johnson, Peter Joostens, Máté Kapitány-Fövény, Emily Karsinti, Falk Kiefer, Maija Konstenius, Frances R. Levin, Mathias Luderer, Wiebren Markus, Frieda Matthys, Franz Moggi, Raul Felipe Palma-Alvarez, Maria Paraskevopoulou, J. Antoni Ramos-Quiroga, Arnt Schellekens, Leila M. Soravia, Norman Therribout, Anil Thomas, Geurt van de Glind, Michiel Willem van Kernebeek, Sabine Vollstädt-Klein, Florence Vorspan, Wim van den Brink, Johan Franck
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Psychiatry
Subjects:
ADHD
SUD
Comorbidity
Online Access:https://doi.org/10.1186/s12888-022-04259-6

Internet

https://doi.org/10.1186/s12888-022-04259-6

Similar Items